tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

NTRA Stock Latest News

Natera submits premarket approval to FDA for Signatera CDx
The FlyNatera submits premarket approval to FDA for Signatera CDx
12d ago
NTRA
Natera completes enrollment in ACES-EMB trial
PremiumThe Fly
Natera completes enrollment in ACES-EMB trial
17d ago
NTRA
Natera’s Prospera featured in interventional study advancing in lung transplant
PremiumThe Fly
Natera’s Prospera featured in interventional study advancing in lung transplant
19d ago
NTRA
Natera announces publication of validation study for Latitude tissue-free assay
PremiumThe Fly
Natera announces publication of validation study for Latitude tissue-free assay
24d ago
NTRA
Natera Targets Endometrial Cancer With New Signatera Trial, Expanding Its MRD Opportunity
PremiumCompany Announcements
Natera Targets Endometrial Cancer With New Signatera Trial, Expanding Its MRD Opportunity
1M ago
NTRA
Natera’s SCORE Study Builds Real-World Evidence for Cancer MRD Testing
PremiumCompany AnnouncementsNatera’s SCORE Study Builds Real-World Evidence for Cancer MRD Testing
1M ago
NTRA
Natera: Accelerating MRD Momentum, Revenue Outperformance, and Improving Cash Profile Support Buy Rating
Premium
Ratings
Natera: Accelerating MRD Momentum, Revenue Outperformance, and Improving Cash Profile Support Buy Rating
1M ago
NTRA
AI Daily: Apple picks Google’s Gemini to run AI-powered Siri
Premium
The Fly
AI Daily: Apple picks Google’s Gemini to run AI-powered Siri
1M ago
KR
LLY
Nvidia enters collaboration with Natera
PremiumThe Fly
Nvidia enters collaboration with Natera
1M ago
NTRA
NVDA
Natera reports preliminary Q4 revenue $660M, consensus $577.62M
PremiumThe Fly
Natera reports preliminary Q4 revenue $660M, consensus $577.62M
1M ago
NTRA
Wayfair upgraded, Instacart initiated: Wall Street’s top analyst calls
PremiumThe Fly
Wayfair upgraded, Instacart initiated: Wall Street’s top analyst calls
1M ago
W
HSY
Natera price target raised to $280 from $240 at TD Cowen
PremiumThe Fly
Natera price target raised to $280 from $240 at TD Cowen
1M ago
NTRA
Exelixis, Natera announce collaboration on STELLAR-316 trial
PremiumThe FlyExelixis, Natera announce collaboration on STELLAR-316 trial
1M ago
EXEL
NTRA
Natera initiated with a Buy at Citi
Premium
The Fly
Natera initiated with a Buy at Citi
1M ago
NTRA
Natera: Leading MRD Position, Expanding Margins, and Premium Valuation Support Buy Rating and $300 Target
Premium
Ratings
Natera: Leading MRD Position, Expanding Margins, and Premium Valuation Support Buy Rating and $300 Target
1M ago
NTRA
TEM, KDK, PSNL: Cathie Wood Loads Up on AI Health Tech, Trims SHOP & ROKU
PremiumMarket News
TEM, KDK, PSNL: Cathie Wood Loads Up on AI Health Tech, Trims SHOP & ROKU
1M ago
GH
KDK
Natera management to meet with Piper Sandler
PremiumThe Fly
Natera management to meet with Piper Sandler
1M ago
NTRA
Natera price target raised to $270 from $230 at Guggenheim
PremiumThe Fly
Natera price target raised to $270 from $230 at Guggenheim
1M ago
NTRA
Natera price target raised to $285 from $260 at Canaccord
PremiumThe Fly
Natera price target raised to $285 from $260 at Canaccord
2M ago
NTRA
Natera publishes findings from CALGB/SWOG 80702 study in JAMA Oncology
PremiumThe FlyNatera publishes findings from CALGB/SWOG 80702 study in JAMA Oncology
2M ago
NTRA
NeoGenomics announce Natera withdrawal of appeal in patent litigation
Premium
The Fly
NeoGenomics announce Natera withdrawal of appeal in patent litigation
2M ago
NEO
NTRA
Natera price target raised to $260 from $250 at JPMorgan
Premium
The Fly
Natera price target raised to $260 from $250 at JPMorgan
2M ago
NTRA

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >